Cargando...

Medroxyprogesterone acetate increases HIV-1 infection of unstimulated peripheral blood mononuclear cells in vitro

OBJECTIVE: Several observational studies suggest that medroxyprogesterone acetate (MPA) injectable contraception may increase a woman’s risk of sexual HIV-1 acquisition. In vitro studies are conflicting, mainly due to differences in the type of progestin studied or activation status of the primary c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:AIDS
Autores principales: Sampah, Maame Efua S., Laird, Gregory M., Blankson, Joel N., Siliciano, Robert F., Coleman, Jenell S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4453018/
https://ncbi.nlm.nih.gov/pubmed/26035316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000000681
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!